These companies are three of the leading manufacturers of continuous glucose monitoring systems.
The medical device maker could benefit from a pending decision by Medicare that could be a game changer.
Yahoo Finance anchors Rachelle Akuffo, Seana Smith and Dave Briffs report on shares of Dexcom rising after Medicare proposed a local coverage determination for its diabetic monitors.
Don't be a prisoner of the moment.
All the blood in the streets is creating opportunities for patient investors.

Why DexCom Was Such a Healthy Stock Today

05:01pm, Tuesday, 04'th Oct 2022
The company had some encouraging news to report about its international sales effort.
Both sell products addressing persistent health issues that are becoming more common.
Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.
There is more to the comparison, and in the sections below, we discuss why we believe DXCM stock will offer better returns than ABT stock in the next three years.

Better Growth Stock: Intuitive Surgical vs. DexCom

10:15am, Wednesday, 28'th Sep 2022
These companies' best days are ahead.
DexCom has been punished on the chart in FY22. Despite this, fundamentals remain strong with high levels of free cash flow and return on investment.
The Health Care sector has easily beaten the broad market so far in 2022. One risk-on niche of Health Care is Medical Devices, down sharply this year.

Could DexCom Stock Help You Become a Millionaire?

09:45am, Thursday, 15'th Sep 2022
The company's profit margin isn't great, but its growth opportunities look incredible.
These growth-dependent healthcare stocks are sinking on the latest inflation update by the Labor Department.
These investments can't make everyone a billionaire, but they could help you get richer.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE